Lu Wen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lu Wen has a total of 238 co-authors. Here are the top co-authors by number of shared publications:
- Fuchou Tang
Peking University
94 shared publications - Haoling Xie
School of Life Sciences, Biomedical Pioneering Innovation Center, Department of Obstetrics and Gynecology, People's Hospital, Peking University, Beijing, China
64 shared publications - Wei Fu
Department of General Surgery, Peking University Third Hospital Peking University Beijing People's Republic of China
56 shared publications - Xin Zhou
Department of General Surgery, Peking University Third Hospital, Peking University, Beijing, China
53 shared publications - Zhenyu Liu
Biomedical Pioneering Innovative Center, School of Life Sciences, Department of General Surgery, Third Hospital, Peking University , Beijing 100871
53 shared publications - Kexuan Chen
Biomedical Pioneering Innovative Center, School of Life Sciences, Peking University, Beijing, China
51 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Elsevier in STAR Protocols
- Vol. 7 (3)
Protocol for detecting cancer in blood using targeted DNA methylation
- 20 August 2026
- Published by Elsevier in STAR Protocols
- Vol. 7 (3)
Open AccessProtocol for detecting cancer in blood using targeted DNA methylation
- Open Access
- 19 August 2026
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (10) , 3961-3978
Methyltransferase-assisted single duplex sequencing for detecting circulating tumor DNA
Accurate circulating tumor DNA (ctDNA) detection is limited by high sequencing errors. To address this, we developed Methyltransferase-Assisted Single Duplex sequencing (MASD-seq), which physically links Watson and Crick strands to enable error correction using double-stranded information within a single read pair. MASD-seq employs enzymatic methyl-sequencing to disrupt strand pairing and uses CpG methyltransferase pre-methylation to enable detection of CpG>TpG and transversion mutations in DNA duplexes. In parallel, MspI digestion enriches tumor CpG>TpG mutations and reduces genome complexity. MASD-seq achieves error rates of 5.4 × 10 −7 for CpG>TpG and 4.1 × 10 −8 for transversions in cell lines, allowing detection of age-associated mutational burdens in blood. Tissue analyses show a 4-fold enrichment of CpG>TpG mutations and a 1.6-fold increase in total mutations in high microsatellite instability (MSI-H) colorectal cancer (CRC), and 3-fold and 1.2-fold enrichments in microsatellite stable (MSS) tumors, respectively, yielding a correctable mutation burden comparable to the whole genome. Clinical testing demonstrates an area under the curve (AUC) of 0.97 for ctDNA detection in CRC patients. MASD-seq is a highly accurate sequencing method, suggesting its potential for future clinical applications.
- 19 August 2026
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (10) , 3961-3978
Open AccessMethyltransferase-assisted single duplex sequencing for detecting circulating tumor DNA
Accurate circulating tumor DNA (ctDNA) detection is limited by high sequencing errors. To address this, we developed Methyltransferase-Assisted Single Duplex sequencing (MASD-seq), which physically links Watson and Crick strands to enable error correction using double-stranded information within a single read pair. MASD-seq employs enzymatic methyl-sequencing to disrupt strand pairing and uses CpG methyltransferase pre-methylation to enable detection of CpG>TpG and transversion mutations in DNA duplexes. In parallel, MspI digestion enriches tumor CpG>TpG mutations and reduces genome complexity. MASD-seq achieves error rates of 5.4 × 10 −7 for CpG>TpG and 4.1 × 10 −8 for transversions in cell lines, allowing detection of age-associated mutational burdens in blood. Tissue analyses show a 4-fold enrichment of CpG>TpG mutations and a 1.6-fold increase in total mutations in high microsatellite instability (MSI-H) colorectal cancer (CRC), and 3-fold and 1.2-fold enrichments in microsatellite stable (MSS) tumors, respectively, yielding a correctable mutation burden comparable to the whole genome. Clinical testing demonstrates an area under the curve (AUC) of 0.97 for ctDNA detection in CRC patients. MASD-seq is a highly accurate sequencing method, suggesting its potential for future clinical applications.
- Open Access
- 22 May 2026
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 17 (10) , 934-953
Epigenetic Dynamics of Human Spermatogenesis and Their Dysregulation in Non-Obstructive Azoospermia
Spermatogenesis is an intricately regulated epigenetic process, yet the exact chromatin dynamics during human meiosis and their systemic failure in non-obstructive azoospermia remain elusive due to the sparsity of single-cell epigenomic data in previous studies. Here, leveraging a high-quality scATAC-seq approach, we mapped over 810,000 cis-regulatory elements across human spermatogenesis. We uncovered a highly synchronized, wave-like activation of master transcription factor networks that precisely orchestrates meiotic progression. Crucially, we traced the dynamic process of opening and closing of chromatin states at meiotic DNA double-strand break hotspot regions at single-cell resolution, defining a transient epigenetic window where thousands of these predefined regions become specifically accessible. In NOA patients, this delicate architecture collapses, leading to severe spermatogenic arrest predominantly at the zygotene stage. We characterize this pathogenesis as the temporal dephasing and decoupling of the activities of master TFs. Furthermore, aberrantly reduced chromatin accessibility at DSB hotspot regions in NOA is potentially associated with defective DSB formation, accompanied by a two- to three-fold increase in sperm aneuploidy. Finally, we establish a functional paradigm for interpreting male infertility by linking non-coding GWAS variants (e.g., the MHC II locus) and rare point mutations to the disruption of cis-regulatory elements. Together, our study provides an unprecedented epigenetic roadmap of human spermatogenesis and redefines NOA pathogenesis from descriptive phenotypes to precise, network-level regulatory failures.
- 22 May 2026
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 17 (10) , 934-953
Open AccessEpigenetic Dynamics of Human Spermatogenesis and Their Dysregulation in Non-Obstructive Azoospermia
Spermatogenesis is an intricately regulated epigenetic process, yet the exact chromatin dynamics during human meiosis and their systemic failure in non-obstructive azoospermia remain elusive due to the sparsity of single-cell epigenomic data in previous studies. Here, leveraging a high-quality scATAC-seq approach, we mapped over 810,000 cis-regulatory elements across human spermatogenesis. We uncovered a highly synchronized, wave-like activation of master transcription factor networks that precisely orchestrates meiotic progression. Crucially, we traced the dynamic process of opening and closing of chromatin states at meiotic DNA double-strand break hotspot regions at single-cell resolution, defining a transient epigenetic window where thousands of these predefined regions become specifically accessible. In NOA patients, this delicate architecture collapses, leading to severe spermatogenic arrest predominantly at the zygotene stage. We characterize this pathogenesis as the temporal dephasing and decoupling of the activities of master TFs. Furthermore, aberrantly reduced chromatin accessibility at DSB hotspot regions in NOA is potentially associated with defective DSB formation, accompanied by a two- to three-fold increase in sperm aneuploidy. Finally, we establish a functional paradigm for interpreting male infertility by linking non-coding GWAS variants (e.g., the MHC II locus) and rare point mutations to the disruption of cis-regulatory elements. Together, our study provides an unprecedented epigenetic roadmap of human spermatogenesis and redefines NOA pathogenesis from descriptive phenotypes to precise, network-level regulatory failures.
- Open Access
A targeted DNA methylation method for detecting gastrointestinal cancer in circulating cell-free DNA
- Open Access
- 22 August 2025
- Published by Elsevier in Trends in Genetics
- Vol. 42 (1) , 46-62
Single-cell omics sequencing technologies: the long-read generation
- 22 August 2025
- Published by Elsevier in Trends in Genetics
- Vol. 42 (1) , 46-62
Open AccessSingle-cell omics sequencing technologies: the long-read generation
- Open Access
- 22 July 2025
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 16 (10) , 873-895
Systematic characterization of full-length RNA isoforms in human colorectal cancer at single-cell resolution
Dysregulated RNA splicing is a well-recognized characteristic of colorectal cancer (CRC); however, its intricacies remain obscure, partly due to challenges in profiling full-length transcript variants at the single-cell level. Here, we employ high-depth long-read scRNA-seq to define the full-length transcriptome of colorectal epithelial cells in 12 CRC patients, revealing extensive isoform diversities and splicing alterations. Cancer cells exhibited increased transcript complexity, with widespread 3′-UTR shortening and reduced intron retention. Distinct splicing regulation patterns were observed between intrinsic-consensus molecular subtypes (iCMS), with iCMS3 displaying even higher splicing factor activities and more pronounced 3′-UTR shortening. Furthermore, we revealed substantial shifts in isoform usage that result in alterations of protein sequences from the same gene with distinct carcinogenic effects during tumorigenesis of CRC. Allele-specific expression analysis revealed dominant mutant allele expression in key oncogenes and tumor suppressors. Moreover, mutated PPIG was linked to widespread splicing dysregulation, and functional validation experiments confirmed its critical role in modulating RNA splicing and tumor-associated processes. Our findings highlight the transcriptomic plasticity in CRC and suggest novel candidate targets for splicing-based therapeutic strategies.
- 22 July 2025
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 16 (10) , 873-895
Open AccessSystematic characterization of full-length RNA isoforms in human colorectal cancer at single-cell resolution
Dysregulated RNA splicing is a well-recognized characteristic of colorectal cancer (CRC); however, its intricacies remain obscure, partly due to challenges in profiling full-length transcript variants at the single-cell level. Here, we employ high-depth long-read scRNA-seq to define the full-length transcriptome of colorectal epithelial cells in 12 CRC patients, revealing extensive isoform diversities and splicing alterations. Cancer cells exhibited increased transcript complexity, with widespread 3′-UTR shortening and reduced intron retention. Distinct splicing regulation patterns were observed between intrinsic-consensus molecular subtypes (iCMS), with iCMS3 displaying even higher splicing factor activities and more pronounced 3′-UTR shortening. Furthermore, we revealed substantial shifts in isoform usage that result in alterations of protein sequences from the same gene with distinct carcinogenic effects during tumorigenesis of CRC. Allele-specific expression analysis revealed dominant mutant allele expression in key oncogenes and tumor suppressors. Moreover, mutated PPIG was linked to widespread splicing dysregulation, and functional validation experiments confirmed its critical role in modulating RNA splicing and tumor-associated processes. Our findings highlight the transcriptomic plasticity in CRC and suggest novel candidate targets for splicing-based therapeutic strategies.
- Open Access
- 1 April 2025
- Published by Elsevier in EBioMedicine
- Vol. 114, 105669
A computational DNA methylation method to remove contaminated DNA from spent embryo culture medium for noninvasive preimplantation genetic testing
- 1 April 2025
- Published by Elsevier in EBioMedicine
- Vol. 114, 105669
Open AccessA computational DNA methylation method to remove contaminated DNA from spent embryo culture medium for noninvasive preimplantation genetic testing
- Top Cited Papers
- 28 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 387 (6741) , eadp4319
Chromatin accessibility landscape of mouse early embryos revealed by single-cell NanoATAC-seq2
In mammals, fertilized eggs undergo genome-wide epigenetic reprogramming to generate the organism. However, our understanding of epigenetic dynamics during preimplantation development at single-cell resolution remains incomplete. Here, we developed scNanoATAC-seq2, a single-cell assay for transposase-accessible chromatin using long-read sequencing for scarce samples. We present a detailed chromatin accessibility landscape of mouse preimplantation development, revealing distinct chromatin signatures in the epiblast, primitive endoderm, and trophectoderm during lineage segregation. Differences between zygotes and two-cell embryos highlight reprogramming in chromatin accessibility during the maternal-to-zygotic transition. Single-cell long-read sequencing enables in-depth analysis of chromatin accessibility in noncanonical imprinting, imprinted X chromosome inactivation, and low-mappability genomic regions, such as repetitive elements and paralogs. Our data provide insights into chromatin dynamics during mammalian preimplantation development and lineage differentiation.
- 28 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 387 (6741) , eadp4319
Top Cited PapersChromatin accessibility landscape of mouse early embryos revealed by single-cell NanoATAC-seq2
In mammals, fertilized eggs undergo genome-wide epigenetic reprogramming to generate the organism. However, our understanding of epigenetic dynamics during preimplantation development at single-cell resolution remains incomplete. Here, we developed scNanoATAC-seq2, a single-cell assay for transposase-accessible chromatin using long-read sequencing for scarce samples. We present a detailed chromatin accessibility landscape of mouse preimplantation development, revealing distinct chromatin signatures in the epiblast, primitive endoderm, and trophectoderm during lineage segregation. Differences between zygotes and two-cell embryos highlight reprogramming in chromatin accessibility during the maternal-to-zygotic transition. Single-cell long-read sequencing enables in-depth analysis of chromatin accessibility in noncanonical imprinting, imprinted X chromosome inactivation, and low-mappability genomic regions, such as repetitive elements and paralogs. Our data provide insights into chromatin dynamics during mammalian preimplantation development and lineage differentiation.
- 7 October 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (11) , 2044-2057
scNanoSeq-CUT&Tag: a single-cell long-read CUT&Tag sequencing method for efficient chromatin modification profiling within individual cells
Chromatin modifications are fundamental epigenetic marks that determine genome functions, but it remains challenging to profile those of repetitive elements and complex genomic regions. Here, we develop scNanoSeq-CUT&Tag, a streamlined method, by adapting modified cleavage under targets and tagmentation (CUT&Tag) to the nanopore sequencing platform for genome-wide chromatin modification profiling within individual cells. We show that scNanoSeq-CUT&Tag can accurately profile histone marks and transcription factor occupancy patterns at single-cell resolution as well as distinguish different cell types. scNanoSeq-CUT&Tag efficiently maps the allele-specific chromatin modifications and allows analysis of their neighboring region co-occupancy patterns within individual cells. Moreover, scNanoSeq-CUT&Tag can accurately detect chromatin modifications for individual copies of repetitive elements in both human and mouse genomes. Overall, we prove that scNanoSeq-CUT&Tag is a valuable single-cell tool for efficiently profiling histone marks and transcription factor occupancies, especially for previously poorly studied complex genomic regions and blacklist genomic regions.
- 7 October 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (11) , 2044-2057
scNanoSeq-CUT&Tag: a single-cell long-read CUT&Tag sequencing method for efficient chromatin modification profiling within individual cells
Chromatin modifications are fundamental epigenetic marks that determine genome functions, but it remains challenging to profile those of repetitive elements and complex genomic regions. Here, we develop scNanoSeq-CUT&Tag, a streamlined method, by adapting modified cleavage under targets and tagmentation (CUT&Tag) to the nanopore sequencing platform for genome-wide chromatin modification profiling within individual cells. We show that scNanoSeq-CUT&Tag can accurately profile histone marks and transcription factor occupancy patterns at single-cell resolution as well as distinguish different cell types. scNanoSeq-CUT&Tag efficiently maps the allele-specific chromatin modifications and allows analysis of their neighboring region co-occupancy patterns within individual cells. Moreover, scNanoSeq-CUT&Tag can accurately detect chromatin modifications for individual copies of repetitive elements in both human and mouse genomes. Overall, we prove that scNanoSeq-CUT&Tag is a valuable single-cell tool for efficiently profiling histone marks and transcription factor occupancies, especially for previously poorly studied complex genomic regions and blacklist genomic regions.
- Open Access
- 12 August 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (8) , 114586
A human fetal cerebellar map of the late second trimester reveals developmental molecular characteristics and abnormality in trisomy 21
- 12 August 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (8) , 114586
Open AccessA human fetal cerebellar map of the late second trimester reveals developmental molecular characteristics and abnormality in trisomy 21